A medical device which facilitates the diagnosis and follow-up of respiratory diseases
Our studies show that respiratory diseases have their own “acoustic signature” identifiable by artificial intelligence better than by the human ear.
The current COVID-19 pandemic affects > 3’5 million people and > 250’000 died in 193 countries. Our AI-driven stethoscope can determine who is affected, predict the outcome of the pulmonary disease in hospitalized patients and alert those confined at home, and their doctor by telemedicine, when their situation deteriorates. Overall medical management and health costs could be tremendously improved.
Asthma affects 350 million people and is the leading chronic disease in children. People with asthma get difficulties to objectively define the severity of symptoms. Fear, anxiety and isolation considerably impair judgement, this is even more exacerbated for a parent who sees his asthmatic child starting an attack. By using our AI-driven stethoscope, each parent will be able to objectively assess the severity of symptoms, be advised in real time on the treatment and the need of a medical consultation to make the best choice for their child’s health.